Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy
Steven A. Pergam(Seattle Cancer Care Alliance), Paul A. Carpenter(Fred Hutch Cancer Center), Sanjeet Dadwal(City Of Hope National Medical Center), Jo‐Anne H. Young(University of Minnesota System), Roy F. Chemaly(The University of Texas MD Anderson Cancer Center), Janet A. Englund(Seattle Children's Hospital), Mini Kamboj(Memorial Sloan Kettering Cancer Center), Jan Storek(Oklahoma State University Medical Center), Bipin N. Savani(Vanderbilt University Medical Center), Joshua A. Hill(Infectious Disease Research Institute), Jeffery Duchin(Public Health – Seattle & King County), Hayley A. Gans(Stanford University)
Cited by 40
Related Papers
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|584
Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy
|Blood|2017|564
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435